Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 17.22B P/E 25.46 EPS this Y -1.30% Ern Qtrly Grth -5.20%
Income 595.69M Forward P/E 21.58 EPS next Y 9.50% 50D Avg Chg 9.00%
Sales 2.88B PEG 5.50 EPS past 5Y 8.49% 200D Avg Chg -4.00%
Dividend N/A Price/Book 22.34 EPS next 5Y 5.62% 52W High Chg -18.00%
Recommedations 2.90 Quick Ratio 1.23 Shares Outstanding 59.36M 52W Low Chg 18.00%
Insider Own 0.06% ROA 11.17% Shares Float 59.20M Beta 0.96
Inst Own 98.16% ROE 54.57% Shares Shorted/Prior 2.75M/2.82M Price 291.77
Gross Margin 59.68% Profit Margin 20.71% Avg. Volume 632,741 Target Price 342.55
Oper. Margin 26.70% Earnings Date Nov 5 Volume 1,400,324 Change 6.33%
About Waters Corporation

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Waters Corporation News
01/03/25 Waters price target raised to $390 from $372 at Evercore ISI
12/23/24 Waters Corporation Named to Dow Jones Sustainability Index for the Fourth Consecutive Year
12/23/24 Bio-Techne Inks New Agreement With Waters Corporation: Stock to Gain?
12/17/24 Waters Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference
12/10/24 Waters Highlights Continued Progress Towards Sustainability Commitments
12/08/24 Waters (NYSE:WAT) Achieves Strong Q3 Performance with Innovative Product Adoption and Revenue Growth
11/21/24 Elf Beauty says short-seller report is 'without merit', analysts defend
11/20/24 Waters Corporation to Present at the Evercore 2024 HealthCONx Conference
11/15/24 What Contributed To The Performance Of Waters Corporation (WAT) In Q3?
11/14/24 Waters Corporation (WAT) Surged on Improved Demand
11/14/24 Should You Invest in the First Trust Water ETF (FIW)?
11/13/24 Waters Corporation Opens State-of-the-Art Precision Manufacturing Facility in Longbridge, UK
11/07/24 Waters New Software Delivers Lab-Centric Business Intelligence and Enables Confident Audit-Readiness
11/04/24 Waters Stock Gains on Earnings & Sales Beat in Q3, Raised View
11/04/24 Waters Corporation Shakes Up Life Sciences Market with 20% Stock Surge
11/02/24 Waters Third Quarter 2024 Earnings: Beats Expectations
11/02/24 Waters Corp (WAT) Q3 2024 Earnings Call Highlights: Strong Revenue and Margin Performance Amid ...
11/02/24 Q3 2024 Waters Corp Earnings Call
11/02/24 Decoding Waters Corp (WAT): A Strategic SWOT Insight
11/01/24 S&P 500 Gains and Losses Today: Waters Stock Surges as Sales Improve
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
KUEBLER CHRISTOPHER A Director Director Aug 04 Sell 291.48 4,000 1,165,920 14,382 08/07/23
KUEBLER CHRISTOPHER A Director Director Aug 04 Option 99.22 4,000 396,880 18,382 08/07/23
CONARD EDWARD Director Director Nov 30 Option 335.42 4,000 1,341,680 75,283 12/01/22
CONARD EDWARD Director Director Nov 30 Sell 334.7 1,059 354,447 74,224 12/01/22
KUEBLER CHRISTOPHER A Director Director May 19 Option 88.71 4,000 354,840 18,064 05/23/22
KUEBLER CHRISTOPHER A Director Director May 19 Sell 328.78 4,000 1,315,120 14,064 05/23/22
Hendrickson Gary E Director Director May 05 Sell 335.74 5,962 2,001,682 2,283 05/09/22
Hendrickson Gary E Director Director May 05 Option 335.69 5,962 2,001,384 8,245 05/09/22
BADDOUR LINDA Director Director Aug 17 Sell 408.99 1,260 515,327 1,797 08/17/21
BADDOUR LINDA Director Director Aug 17 Option 183.41 1,260 231,097 3,057 08/17/21
Buck Sherry SVP and CFO SVP and CFO Nov 02 Option 141.74 17,499 2,480,308 21,219 11/02/20
Buck Sherry SVP and CFO SVP and CFO Nov 02 Sell 221.62 17,499 3,878,128 3,720 11/02/20